2026-06-03T19:09:23Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/ahr.000013 2017-05-29 PTZ.AHR:VOL3

Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports Meng-Lan Wang Dong-Mei ZhangEn-Qiang Chen<p>Entecavir (ETV) is an oral nucleoside analog inhibitor of hepatitis B virus (HBV) DNA polymerase, which is widely used in patients with chronic hepatitis B (CHB). Despite the excellent safety data of this agent, the adverse events of headache, diarrhea, nausea and vomiting are recorded in the drug instruction of ETV. Here we report two CHB patients with ETV-associated constipation in whom symptom fully disappeared following ETV withdrawal.</p> Archives of Hepatitis Research - Peertechz Publications 2017-05-29 Case Report https://doi.org/10.17352/ahr.000013 en Copyright © Meng-Lan Wang et al.